Plasma glyceraldehyde level in healthy subjects after glucose or fructose injestion

Plasma glyceraldehyde level in healthy subjects after glucose or fructose injestion - Plasma glyceraldehyde level in healthy subjects after glucose or fructose injestion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000048429

Enrollment

Registered

2022-08-08

Start date

2023-01-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects

Interventions

Take high dose glucose. Take high dose fructose. Take low dose glucose. Take high dose fructose.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate with written consent.

Exclusion criteria

Exclusion criteria: 1.Herditary fructose intolerance 2.History of gastrointestinal surgery 3.Under treatment of diabetes, hypertension, hyperlipidemia, or hyperuricemia 4.History of cerebrovascular disease or cardiovascular disease 5.Severe impairment of liver function or liver cirrhosis 6.Severe impairment of renal function 7.Under corticosteroid therapy 8.During pregnancy or lactation period

Design outcomes

Primary

Measure	Time frame
Plasma glyceraldehyde levels after oral glucose/ fructose tolerance test.	—

Countries

Japan

Contacts

Public ContactYoko Ueba

Graduate School of Medicine, Kyoto University Department of Diabetes, Endocrinology and Nutrition

yokoueba@kuhp.kyoto-u.ac.jp075-751-3560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026